Target Name: MADCAM1
NCBI ID: G8174
Review Report on MADCAM1 Target / Biomarker Content of Review Report on MADCAM1 Target / Biomarker
MADCAM1
Other Name(s): MACAM1 | MAdCAM-1 | hMAdCAM-1 | Mucosal vascular addressin cell adhesion molecule 1 | MADCA_HUMAN | Mucosal addressin cell adhesion molecule-1 | Mucosal addressin cell adhesion molecule 1 (isoform a) | Mucosal addressin cell adhesion molecule 1 | Mucosal vascular addressin cell adhesion molecule 1, transcript variant 2 | MADCAM1 variant 1 | Mucosal vascular addressin cell adhesion molecule 1, transcript variant 1 | mucosal vascular addressin cell adhesion molecule 1 | Mucosal addressin cell adhesion molecule 1 precursor | MADCAM1 variant 2 | Mucosal addressin cell adhesion molecule 1 (isoform b)

Understanding MADCAM1: A Protein's Role in Modulating Serotonin, Pain and Inflammation

MADCAM1 (MACAM1) is a protein that is expressed in various tissues of the body, including the brain. It is a member of the neurotrophic factor receptor (NTR) family, which is a family of transmembrane proteins that play a crucial role in the development and maintenance of neural tissue. MADCAM1 is known for its ability to interact with the neurotransmitter serotonin, which is a chemical that plays a critical role in the regulation of mood, appetite, and sleep.

One of the key functions of MADCAM1 is its role in modulating the levels of serotonin in the brain. MADCAM1 is known to interact with the serotonin transporter, which is a protein that is responsible for reabsorbing serotonin from the brain. When MADCAM1 is activated, it can cause the transporter to release more serotonin into the brain, which can lead to increased levels of mood enhancement and decreased levels of anxiety and depression.

Another important function of MADCAM1 is its role in the regulation of pain. MADCAM1 is known to interact with the nociceit diffuse receptor, which is a protein that is responsible for mediating pain signals in the body. When MADCAM1 is activated, it can cause the nociceit diffuse receptors to release more pain signals, which can lead to increased pain sensitivity.

In addition to its role in modulating the levels of serotonin and pain, MADCAM1 is also known for its role in the regulation of inflammation. MADCAM1 is a known to interact with the nuclear factor kappa B (NF-kappa-B), a protein that is involved in the regulation of inflammation. When MADCAM1 is activated, it can cause the NF-kappa-B to activate, leading to increased inflammation.

Despite its many important functions, MADCAM1 is not yet a well-established drug target. There are currently no FDA-approved drugs that are specifically designed to target MADCAM1. However, researchers are actively working to identify potential drug targets for MADCAM1, and there is a growing interest in the potential use of MADCAM1 as a biomarker for various neurological disorders.

One of the challenges in studying MADCAM1 is its complex structure. MADCAM1 is a large protein that contains multiple domains, including an extracellular domain, a transmembrane domain, and an intracellular domain. The functions of MADCAM1 are achieved by the interactions between these different domains.

In addition to its complex structure, MADCAM1 is also known for its ability to interact with other proteins. For example, MADCAM1 has been shown to interact with the neurotransmitter dopamine, which is a chemical that plays a critical role in the regulation of mood, appetite , and reward.

MADCAM1 is also known to interact with the protein brain-derived neurotrophic factor (BDNF), which is a protein that is involved in the regulation of neural stem cells. BDNF is a potent neurotrophic factor that can promote the survival and proliferation of neural stem cells , and MADCAM1 has been shown to interact with it.

In conclusion, MADCAM1 is a protein that is expressed in various tissues of the body, and it plays a crucial role in the regulation of serotonin, pain, and inflammation. While MADCAM1 is not yet a well-established drug target, there is a growing interest in the potential use of MADCAM1 as a biomarker for various neurological disorders. Further research is needed to fully understand the functions of MADCAM1 and its potential as a drug target.

Protein Name: Mucosal Vascular Addressin Cell Adhesion Molecule 1

Functions: Cell adhesion leukocyte receptor expressed by mucosal venules, helps to direct lymphocyte traffic into mucosal tissues including the Peyer patches and the intestinal lamina propria. It can bind both integrin alpha-4/beta-7 and L-selectin, regulating both the passage and retention of leukocytes. Isoform 2, lacking the mucin-like domain, may be specialized in supporting integrin alpha-4/beta-7-dependent adhesion strengthening, independent of L-selectin binding

The "MADCAM1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MADCAM1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MADD | MAEA | MAEL | MAF | MAF1 | MAFA | MAFA-AS1 | MAFB | MAFF | MAFG | MAFIP | MAFK | MAFTRR | MAG | MAGEA1 | MAGEA10 | MAGEA11 | MAGEA12 | MAGEA13P | MAGEA2 | MAGEA2B | MAGEA3 | MAGEA4 | MAGEA5P | MAGEA6 | MAGEA7P | MAGEA8 | MAGEA9 | MAGEA9B | MAGEB1 | MAGEB10 | MAGEB16 | MAGEB17 | MAGEB18 | MAGEB2 | MAGEB3 | MAGEB4 | MAGEB5 | MAGEB6 | MAGEB6B | MAGEC1 | MAGEC2 | MAGEC3 | MAGED1 | MAGED2 | MAGED4 | MAGED4B | MAGEE1 | MAGEE2 | MAGEF1 | MAGEH1 | MAGEL2 | MAGI1 | MAGI1-AS1 | MAGI1-IT1 | MAGI2 | MAGI2-AS3 | MAGI3 | MAGIX | MAGOH | MAGOH-DT | MAGOHB | MAGT1 | MAIP1 | MAJIN | Major histocompatibility complex (MHC) antigen | Major Histocompatibility Complex Class I | Major histocompatibility complex class II antigens | MAK | MAK16 | MAL | MAL2 | MALAT1 | Malate dehydrogenase | MALL | MALLP2 | MALRD1 | MALSU1 | MALT1 | MAMDC2 | MAMDC2-AS1 | MAMDC4 | MAML1 | MAML2 | MAML3 | MAMLD1 | MAMSTR | MAN1A1 | MAN1A2 | MAN1B1 | MAN1B1-DT | MAN1C1 | MAN2A1 | MAN2A2 | MAN2B1 | MAN2B2 | MAN2C1 | MANBA | MANBAL | MANCR